Health SciencesWordPress

Europe PMC News Blog

Europe PMC News Blog
Home PageAtom Feed
language
Published
Author Europe PMC Team

[[By Luisa Robbez-Masson (Barts Cancer Institute, Queen Mary University, London, UK)]{style=“font-family: "helvetica neue" , "arial" , "helvetica" , sans-serif; font-size: small;”}]{style=“font-size: 11pt; line-height: 115%; mso-ansi-language: EN-GB; mso-ascii-theme-font: minor-latin; mso-bidi-font-family: "Times New Roman"; mso-bidi-language: AR-SA; mso-bidi-theme-font: minor-bidi; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US;

Published
Author Europe PMC Team

[ by Ian Le Guillou, Department of Biochemistry, University of Cambridge ]{style=“font-family: "helvetica neue" , "arial" , "helvetica" , sans-serif;”} [Although contradictory to the hopes of the Access to Understanding competition, writing about the work described in ]{style=“font-family: "helvetica neue" , "arial" , "helvetica" , sans-serif;”}[’NLK is a Novel Therapeutic Target for PTEN Deficient Tumour Cells’]{style=“color: black;